Drug intelligence / Profile preview

Conceptio EA

Development stage: Unknown
Lead developer: EA Pharma
Modality: Small Molecules
Administration: Oral

Overview

Conceptio EA (marketed as Conceptio Homme) is a multi-ingredient antioxidant dietary supplement developed by EA Pharma (Laboratoire des Granions) to support male reproductive health. It is specifically formulated for men with oligoasthenozoospermia to improve sperm count, motility, and DNA integrity. The supplement contains a combination of L-carnitine, zinc, selenium, coenzyme Q10, docosahexaenoic acid (DHA), and vitamins (E, B6, B9, B12). It works by mitigating oxidative stress and providing nutritional support for spermatogenesis. The product is typically administered as a daily regimen involving both sachets and capsules.

Brand names: Conceptio HommeConceptio
Other names: Conceptio (EA)

Beyond the preview

Go deeper on Conceptio EA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conceptio EA.

Explore the full profile